Aptevo Therapeutics Inc.

10/29/2024 | Press release | Distributed by Public on 10/29/2024 06:30

Aptevo Therapeutics and Alligator Bioscience to Present Additional Positive Interim Phase 1 Data Evaluating ALG.APV-527 Monotherapy in Multiple Solid Tumor Types, at SITC 2024

Read this content
Click here to read the original version at the source's official website. The text of this article is not available at the moment.